{"slideshow_credits": null, "snippet": "A Food and Drug Administration finding has given ammunition to consumer advocates who say the quality of generic drugs needs to be improved.", "abstract": "Food and Drug Administration will look more closely at how generic companies make extended release drugs following its investigation of Impax Laboratories, which produced defective version of common antidepressant Wellbutrin; finding is rare departure for FDA, which has long insisted that generics are as effective as their brand-name counterparts.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Katie", "role": "reported", "lastname": "THOMAS", "rank": 1, "organization": ""}], "original": "By KATIE THOMAS", "contributor": ""}, "web_url": "http://www.nytimes.com/2012/11/01/business/fda-increases-scrutiny-of-some-generic-drugs.html", "lead_paragraph": "A Food and Drug Administration finding has given ammunition to consumer advocates who say the quality of generic drugs needs to be improved.", "headline": {"seo": "F.D.A. Increases Scrutiny of Some Generic Drugs", "main": "An Increase in Scrutiny for Generics", "print_headline": "An Increase In Scrutiny For Generics"}, "_id": "5091a98e95e998af7118a7bc", "word_count": "1001", "multimedia": [], "pub_date": "2012-11-01T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Generic Brands and Products", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Food and Drug Administration", "name": "organizations", "is_major": "Y", "rank": "3"}, {"value": "Antidepressants", "name": "subject", "is_major": "Y", "rank": "4"}, {"value": "Depression (Mental)", "name": "subject", "is_major": "N", "rank": "5"}, {"value": "Impax Laboratories Inc", "name": "organizations", "is_major": "Y", "rank": "6"}], "blog": [], "subsection_name": null, "type_of_material": "News"}